Abstract
Insulin resistance (IR) and abdominal obesity are key in osteoarthritis (OA) development. The triglyceride glucose (TyG) index, along with indicators such as the visceral adiposity index (VAI), and lipid accumulation product (LAP), are increasingly used to measure IR. This study aims to explore the associations between surrogate IR indexes and OA, assessing their diagnostic efficacy within American populations. This study included 14,715 adults from the National Health and Nutrition Examination Survey 2003–2016. Logistic regression models and restricted cubic spline were used to explore the relationship between surrogate IR indexes and OA. Receiver operating characteristic curves were constructed to assess the diagnostic efficacy of these indices, with the area under the curve (AUC) as the metric. TyG, glucose triglyceride-waist circumference (TyG-WC), glucose triglyceride-body mass index (TyG-BMI), glucose triglyceride-waist height ratio (TyG-WHtR), VAI and LAP were significantly and positively associated with the prevalence of OA (all p < 0.01). After adjusting for various potential confounders, TyG-WC, TyG-BMI, TyG-WHtR and LAP remained significantly correlated with the prevalence of OA. Furthermore, restricted cubic spline revealed a nonlinear association between TyG-BMI, TyG-WHtR and LAP (all P-non-linear < 0.05). Receiver operating characteristic curves indicated that TyG-WHtR (AUC 0.633) demonstrated more robust diagnostic efficacy. Additionally, the sensitivity analysis produced results consistent with the primary findings. TyG and its combination with obesity indicators and LAP, are positively associated with the prevalence of OA, with TyG-WHtR showing the highest diagnostic efficacy.
Similar content being viewed by others
Introduction
Osteoarthritis (OA) is a multifaceted joint disease involving alterations in articular cartilage, subchondral bone, ligaments, capsule, synovial membrane and periarticular muscles. It is a prevalent degenerative condition in the elderly, a major cause of chronic pain and disability, and a significant burden on global public health resources1,2. The prevalence of this illness has significantly increased in recent decades, primarily due to the aging population and rising obesity rates3. It is estimated that approximately 595 million people (7.6%) worldwide had this condition in 2020, with projections suggesting a rise to 1 billion by 2050. The highest age-standardised prevalence rates are observed in the Asia-Pacific, North America, and Eastern Europe regions2.
Previous studies have drawn a link between OA and metabolic syndrome (MetS), which is characterized by hypertension, hyperglycemia, dyslipidemia, and abdominal obesity4,5,6,7. Insulin resistance (IR), a crucial component of MetS, refers to a reduced responsiveness of insulin in target tissues or organs. The hyperinsulinemic-euglycemic clamp serves as the gold standard for diagnosing IR, but its invasiveness, complexity, and cost limit its use in epidemiological studies. While the homeostasis model assessment of IR is convenient to use, it is not suitable for diagnosing patients undergoing insulin therapy8,9. In this context, alternative markers derived from blood glucose and lipid profiles, as well as specific anthropometric measurements, such as the visceral adiposity index (VAI), lipid accumulation product (LAP), and triglyceride-glucose index (TyG), are increasingly employed as simple and effective tools for identifying IR10,11,12. Extensive research indicates that these surrogate IR indexes are significantly associated with the prevalence of cardiovascular disease10, ischemic stroke13, and diabetes14. Obesity is a major contributor to OA and interacts with IR in its development. Recent studies have combined the TyG with various obesity measures to develop new indices, such as glucose triglyceride-waist circumference (TyG-WC), glucose triglyceride-body mass index (TyG-BMI), and glucose triglyceride-waist height ratio (TyG-WHtR). These new indices demonstrate superior accuracy and sensitivity in assessing metabolic disease risk compared to TyG, waist height ratio (WHtR), or body mass index (BMI) alone15,16,17.
Recent studies suggest that LAP, TyG, and TyG combined with obesity measures may predict OA11,18,19. However, the relationship between surrogate IR indexes and OA needs further exploration. Using data from the National Health and Nutrition Examination Survey (NHANES) 2003–2016, this study aims to investigate the associations between surrogate IR indexes and OA, evaluating their diagnostic efficacy to identify the superior indicators for assessing OA.
Materials and methods
Data source and study participants
This cross-sectional study utilizes data from seven NHANES cycles (2003–2016), encompassing 71,058 participants who underwent extensive population surveys, laboratory examinations, and health survey questionnaires. To ensure accuracy and reliability, we implemented rigorous data screening and exclusion processes. Since our study focused on surrogate IR indexes in adults, participants being under 20 years old (n = 31,837) were excluded. We further excluded participants with missing data for OA (n = 3517), physical measurement indicators such as weight, height and waist circumference (WC) (n = 3438), and TyG and TyG-related parameters (n = 17,551). Finally, this study included a large national representative sample (n = 14,715) of the general adult American population. The flowchart of the study is shown in Fig. 1.
All participants have signed a written informed consent form, which has been approved by the Ethics Review Committee of the National Center for Health Statistics (Protocol #98-12, Protocol #2005-06, Continuation of Protocol #2005-06, Protocol #2011-17 and Continuation of Protocol #2011-17). The study was designed in accordance with the Guidelines for Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) for reporting cross-sectional studies20 .
Definitions of independent variables
Baseline fasting blood glucose (FBG), glycated hemoglobin and triglycerides (TG) were obtained when participants provided blood samples. Body weight, height, and WC were measured during physical examinations at a mobile health center. All these variables were treated as continuous variables15.
The calculation formula for TyG, BMI, WHtR, TyG-WC, TyG-BMI, TyG-WHtR, VAI and LAP were provided in Table S1. Participants were divided into four quartiles (Q1, Q2, Q3, Q4) for each measure, with Q1 as the reference group21.
Assessment of OA
Self-reported arthritis is frequently utilized for case definition in epidemiological research22. March23 et al. indicates an 81% concordance between self-reported OA and clinically diagnosed OA, demonstrating that self-reporting of OA is generally reliable. Participants who answered “Yes” to the question “Has a doctor or other health professional ever told you that you had arthritis?” were classified as having arthritis. These participants were further queried “What type of arthritis was it?” Those who selected the option of “Osteoarthritis” (2003–2010) or “Osteoarthritis or degenerative arthritis” (2011–2016) were diagnosed with OA19,24.
Assessment of covariates
To assess potential confounding factors, covariates selected based on prior research and clinical rationale included age, gender, race, education level, poverty income ratio (PIR), lifestyle factors (drinking and smoking), and chronic diseases (hypertension and diabetes)25,26.
Age (years) was considered as a continuous variable. Gender was classified as male or female. Race was divided into five groups of Non-Hispanic White, Non-Hispanic Black, Mexican American, other races and other Hispanic. Education was divided into three categories: < High School, high school, and > High School. The PIR was calculated by dividing household (or individual) income by the poverty threshold for the survey year, and was categorized into three groups: <1.3, 1.3–3.49, and ≥ 3.5. Smoking status was classified as current smoker, former smoker, and never smoker based on responses to the questions: “Have you smoked at least 100 cigarettes in your entire life?” and “Do you currently smoke cigarettes?”. Alcohol consumption was defined by the response to the question: “Have you had at least 12 drinks of any type of alcoholic beverage in any one year?” and categorized into two groups: yes or no.
Hypertension was defined as self-reported diagnosis, use of antihypertensive medication, or blood pressure ≥ 140/90 mmHg. Diabetes status was classified as “diabetes”: based on any of the following criteria: self-reported diagnosis, glycosylated hemoglobin (HbA1c) level ≥ 6.5%, FBG level ≥ 7.0 mmol/L, or use of diabetes medications or insulin27.
Statistical analysis
Participants were classified into two groups based on the presence or absence of OA. Continuous variables are represented as mean ± standard deviation (SD) and compared using the Wilcoxon rank-sum test, while categorical variables are shown as counts (n) and percentages (%) and compared with the chi-square test. Associations between surrogate IR indexes (TyG, TyG-WC, TyG-BMI, TyG-WHtR, VAI, LAP) and OA were evaluated using as categorical form.
We used three logistic regression models to explore the associations between surrogate IR indexes and OA. In Model 1, no covariates were adjusted; Model 2 adjusted for age and gender; Model 3 further adjusted for race, education level, PIR, drinking, smoking, hypertension, and diabetes. Missing covariate values were imputed using multiple imputation. Results are presented as odds ratios (OR) with 95% confidence intervals (CI). Trend analysis treated quartiles as a continuous variable. Restricted cubic spline (RCS) analysis assessed linear and nonlinear dose-response relationships between surrogate IR indexes and OA, with four knots at the 5th, 35th, 65th, and 95th percentiles. Receiver operating characteristic (ROC) curves evaluated diagnostic efficacy, with specificity on the X-axis and sensitivity on the Y-axis, and the area under the curve (AUC) indicating prediction accuracy. Stratification and interaction analyses by gender, age (< 60 years and ≥ 60 years), and smoking status (current smoker, former smoker, and never smoked) examined the effects of TyG-WHtR on OA. In sensitivity analysis, participants with missing covariates, those using lipid-lowering therapy, and individuals with current cancer or pregnancy were excluded. Multiple logistic regression models were then employed to evaluate the association between TyG-WHtR and OA. To ensure representativeness of the American adult population, we followed the weighting guidelines from the National Center for Health Statistics (NCHS) and applied the “fasting sub-sample mobile examination center weight” for weighting28. Statistical analyses were conducted using R software (version 4.3.0), with significance defined as p < 0.05 (two-sided).
Results
Baseline characteristics of participants
This study included 14,715 participants (mean age 45.9 ± 16.5 years), comprising 7205 males (49%) and 7,510 females (51%), representing 194,760,632 American adults, 11% of whom have OA. Table 1 details the demographic and baseline characteristics of OA versus non-OA groups. Increased OA prevalence was observed in higher quartiles of TyG-WC, TyG-BMI, TyG-WHtR, VAI and LAP (all p < 0.001), a trend not observed in the non-OA population.
Association between surrogate IR indexes and OA
Three logistic regression models were constructed to evaluate the associations between surrogate IR indices and OA (Table 2). In the unadjusted model (Model 1), all indices—TyG, TyG-WC, TyG-BMI, TyG-WHtR, VAI and LAP—were positively associated with OA.
This association remained after adjusting for age and sex (Model 2). After further adjusting for race, education, PIR, alcohol use, smoking status, hypertension, and diabetes (Model 3), TyG-WC, TyG-BMI, TyG-WHtR and LAP remained significantly associated with increased the prevalence of OA (all p < 0.01). When dividing TyG-WC, TyG-BMI, TyG-WHtR and LAP into quartiles, participants in the highest quartile exhibited a higher prevalence of OA compared to those in the lowest quartile, with ORs [95% CI] for Q4 of 2.3475 [1.8388, 2.9971], 2.4969 [1.9808, 3.1474], 2.2444 [1.7604, 2.8615] and 1.8395 [1.4515, 2.3312]. All p for trend were significant.
Additionally, we used RCS to evaluate the associations of TyG, TyG-BMI, TyG-WC, TyG-WHtR, VAI and LAP with OA. After adjusting for all confounders in model 3, only the associations of TyG-BMI (p-overall < 0.0001, p-non-linear = 0.0434), TyG-WHtR (p-overall < 0.0001, p-non-linear = 0.0013) and LAP (p-overall < 0.0001, p-non-linear = 0.0029) displayed a nonlinear relationship with OA incidence (Fig. 2).
Restricted cubic spline plot model. The adjusted restricted cubic spline plot model shows an association between surrogate insulin resistance indexes and OA among all participants. The model was adjusted for gender, age, race, education level, PIR, drinking and smoking status, hypertension and diabetes (VAI and LAP did not need adjust for gender). The red solid line and the purple shaded area represent the estimated odds ratio and its 95% confidence interval, respectively.
Diagnostic efficacy of surrogate IR indexes for OA
To further investigate the diagnostic efficacy of these indices for OA, we performed ROC curve analysis. The results indicated that TyG-WHtR had the highest diagnostic efficacy (AUC 0.633), suggesting that TyG-WHtR may be a more suitable indicator for assessing OA (Fig. 3).
Stratified and sensitivity analyses of potential effect modifiers
To further assess the association between TyG-WHtR and OA, we stratified the population by age, sex, and smoking status and conducted interactive analyses. A significant interaction was observed between TyG-WHtR and both age (p < 0.001) and smoking status (p = 0.001), while no interaction was found with sex (p = 0.754). After fully adjusting for confounders such as sex, race, education level, PIR, alcohol consumption, smoking status, hypertension, and diabetes, TyG-WHtR was positively associated with OA in both older (≥ 60 years) and younger (< 60 years) populations. When divided into quartiles, the ORs [95% CIs] for the younger population were: Q2: 1.0176 [1.0028, 1.0326], p = 0.020; Q3: 1.0353 [1.0165, 1.0545], p < 0.001; and Q4: 1.0611 [1.0383, 1.0844], p < 0.001. In the older population, higher levels of TyG-WHtR also significantly impacted the development of OA, with an OR [95% CI] for Q4 of 1.1130 [1.0468, 1.1834], p < 0.001. The results of the study stratified by sex indicated that higher TyG-WHtR levels significantly affected the incidence of OA in both males and females, demonstrating a positive correlation with ORs [95% CIs] for Q4: 1.0440 [1.0162, 1.0726] in males (p = 0.002) and 1.0664 [1.0364, 1.0973] in females (p < 0.001). Subgroup analyses based on smoking status indicated that TyG-WHtR significantly impacted OA development in both nonsmoking and former smoking populations, particularly at higher TyG-WHtR levels. The ORs [95% CIs] for Q4 were 1.0596 [1.0261, 1.0942] in the nonsmoking population (p < 0.001) and 1.0666 [1.0164, 1.1194] in the former smoking population (p = 0.009) (Fig. 4).
Associations between TyG-WHtR and OA in different subgroups. Analysis of age was adjusted for gender, race, education level, PIR, drinking and smoking status, hypertension and diabetes. Analysis of gender was adjusted for age, race, education level, PIR, drinking and smoking status, hypertension and diabetes. Analysis of smoking status was adjusted for gender, age, race, education level, PIR, drinking status, hypertension and diabetes. OR odds ratio, CI Confidence Interval, Ref Reference, Q Quartile.
To assess the robustness of the association between IR and OA, we accounted for potential confounders including lipid-lowering therapy, cancer, and pregnancy. Sensitivity analyses were conducted by excluding participants with missing covariate data (n = 1997), those on lipid-lowering therapy (n = 2482), and those with a current diagnosis of cancer or pregnancy (n = 1532). Further analysis of the association between TyG-WHtR and OA revealed that TyG-WHtR remained significantly associated with OA risk after full adjustment for confounding factors (all p < 0.001), indicating a robust relationship between TyG-WHtR and OA (Table S2).
Discussion
OA accounts for a significant proportion of the population, is one of the leading causes of disability among the elderly, and represents a considerable social burden. Therefore, identifying potential risk and prognostic factors could lead to cost savings in the management of this population29. IR and obesity are critical factors influencing the development of OA7, with the TyG serving as a reliable measure for assessing IR9,12,30. This index relies exclusively on the patient’s TG and FBG levels, making it highly accessible and cost-effective. Furthermore, TyG has been associated with the prevalence of OA11, diabetes mellitus31, cardiovascular disease15, and hypertension32. Recent studies have indicated that novel TyG-related indexes such as TyG-WC, TyG-BMI, and TyG-WHtR exhibit superior predictive abilities compared to TyG alone regarding diseases, including pre-diabetes and cardiovascular conditions13,16,33. While previous research has shown that the VAI, LAP effectively assess IR status33, which is linked to diabetes34, stroke35, atherosclerosis36, and coronary artery disease33, the relationships between these surrogate IR indexes and the prevalence of OA, as well as their advantages for OA diagnostic efficacy, remain unclear.
This study aims to explore the associations between the VAI, LAP, and TyG combinations with obesity indicators, concerning the prevalence of OA. Additionally, it compares the diagnostic efficacy of surrogate IR indices. These results are consistent with earlier studies. Zhang19 et al.. found that TyG-BMI and TyG-WHtR were positively associated with arthritis prevalence in both Chinese and American populations. Furthermore, these indices demonstrated stronger correlations with arthritis diagnoses compared to TyG. Liu33 et al. demonstrated that TyG, TyG-WC, TyG-BMI, TyG-WHtR and LAP were independently associated with an increased prevalence of coronary heart disease. Notably, TyG-WHtR and TyG-BMI exhibited significant predictive capacities. Additionally, Liu36 et al. reported that Chinese visceral adiposity index, TyG-WC, TyG-WHtR, and LAP were independently associated with an increased prevalence of carotid atherosclerosis, with Chinese visceral adiposity index and TyG-WHtR emerging as the most suitable predictive markers.
Another finding of this study is that the associations between surrogate IR indexes, particularly TyG-WHtR and OA vary across populations with differing characteristics. Specifically, the associations of TyG-WHtR with OA are more pronounced among younger individuals. The results of a previous study by Puenpatom37 et al. indicated an increased prevalence of MetS and OA among younger American adults, with this association diminishing with age, which parallels our findings. TyG-WHtR significantly correlated with OA incidence in both sexes, suggesting that there is no sex difference in the increased prevalence of OA due to insulin resistance and obesity. Controversy persists regarding the relationship between smoking and OA. Numerous clinical studies across diverse populations have reported a negative association between smoking and OA incidence38,39,40,41. In contrast, large national studies in the United States reveal a positive correlation between smoking and the prevalence of adult OA42. While the findings from the Osteoarthritis Initiative (OAI) in the American and the Tasmanian Older Adult Cohort (TASOAC) in Australia did not demonstrate a significant association between smoking and OA incidence43, a trend that is echoed in cross-sectional studies from Korea44 and Denmark45. The present study identified a positive association between TyG-WHtR and the prevalence of OA in non-smokers, a similar association among former smokers. Previous studies have shown that inflammatory markers are significantly elevated in smokers compared to non-smokers. Cigarette smoke promotes the release of inflammatory cytokines, such as tumor necrosis factor-ɑ (TNF-ɑ), interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hsCRP), which plays a crucial role in the progression of OA19,46,47. Moreover, nicotine impairs osteoblast function, leading to tissue hypoxia, which subsequently activates osteoclasts and promotes bone resorption48. On the other hand, obesity remains a major risk factor for OA, while smokers tend to be thinner than non-smokers and generally have a lower risk of OA. This may explain the lack of statistically significant differences observed in the evaluation of OA incidence among smokers using the TyG-WHtR. These findings indicate that, regardless of nonsmoking or former smoking, actively improving IR and managing obesity can significantly decrease the likelihood of OA development.
Insulin is a crucial regulator of synovial inflammation and catabolism, and individuals with IR frequently exhibit MetS, such as obesity. IR reduces the body’s capacity to suppress the production of inflammatory mediators, thereby increasing the risk of OA, particularly in obese individuals49. Obesity impacts cartilage tissue not only by imposing excessive mechanical load but also by inducing inflammatory responses associated with adipose tissue. In individuals who are overweight or obese, adipose deposition results in elevated plasma levels of TNF-ɑ and IL-6. TNF-ɑ inhibits the tyrosine phosphorylation of insulin receptors and insulin receptor substrate 1 (IRS-1) kinases while promoting the serine phosphorylation of IRS-1, leading to dysfunction in adipocytes and skeletal muscle cells, which in turn contributes to IR in both adipose and non-adipose tissues. The development of IR prompts the pancreas to produce additional insulin, further enhancing fat synthesis and storage. Obesity influences the development of OA not only by directly impacting cartilage tissue through excessive mechanical loading but also by inducing inflammatory responses associated with adipose tissue50. In individuals who are overweight or obese, adipose deposition leads to increased plasma levels of TNF-ɑ and IL-651. TNF-ɑ inhibits the tyrosine phosphorylation of insulin receptors and IRS-1 kinases while promoting serine phosphorylation of IRS-1, resulting in dysfunction of adipocytes and skeletal muscle cells, which in turn leads to IR across both adipose and non-adipose tissues52. The onset of IR prompts the pancreas to produce additional insulin, further enhancing fat synthesis and storage53. Furthermore, preclinical and clinical findings indicate that MetS and obesity promote the polarization of macrophages from a reparative anti-inflammatory M2 phenotype to a pro-inflammatory M1 phenotype, leading to the secretion of substantial quantities of cytokines and mediators, including TNF-ɑ, IL-6, interleukin-2, and interleukin-1, which exacerbate synovitis and cartilage degradation54,55,56. The vicious cycle between IR and obesity further contributes to the development of OA.
The present study had the following strengths. First, we investigate the association between IR and OA using multiple surrogate IR indexes, while identifying the most suitable indicators for assessing OA. This study yielded largely consistent results across various subgroups and sensitivity analyses, further validating our findings. Second, by considering the impact of the vicious cycle between IR and obesity on OA development, the surrogate IR indexes effectively integrate responses from both IR and obesity to enhance OA assessment. However, this study also had some limitations. Firstly, the reliance on personal interviews to diagnose OA without relevant laboratory data, such as anti-cyclic citrullinated peptide antibodies and rheumatoid factor, may introduce inaccuracies in data collection, despite the reported high concordance between self-reported and clinically defined OA. Secondly, the cross-sectional study design prevents the establishment of causal relationships between the studied variables, necessitating further prospective studies and intervention trials to acquire more robust evidence.
Conclusion
In conclusion, this cross-sectional NHANES study (2003–2016) indicates that surrogate IR indexes are positively associated with OA. Combining multiple indices display superior diagnostic relevance compared to TyG, with TyG-WHtR showing the highest diagnostic efficacy.
Data availability
Data are publicly available at https://www.cdc.gov/nchs/nhanes.
Abbreviations
- OA:
-
Osteoarthritis
- NHANES:
-
National Health and Nutrition Examination Survey
- MetS:
-
Metabolic syndrome
- IR:
-
Insulin resistance
- VAI:
-
Visceral adiposity index
- LAP:
-
Lipid accumulation product
- TyG:
-
Triglyceride-glucose index
- TyG-WC:
-
Glucose triglyceride-waist circumference
- TyG-BMI:
-
Glucose triglyceride-body mass index
- TyG-WHtR:
-
Glucose triglyceride-waist height ratio
- BMI:
-
Body mass index
- WHtR:
-
Waist height ratio
- WC:
-
Waist circumference
- FBG:
-
Fasting blood glucose
- TG:
-
Triglycerides
- PIR:
-
Poverty income ratio
- SD:
-
Standard deviation
- OR:
-
Odds ratio
- CI:
-
Confidence intervals
- RCS:
-
Restricted cubic spline
- ROC:
-
Receiver operating characteristic
- AUC:
-
Area under the curve
- NCHS:
-
National Center for Health Statistics
- TNF-ɑ:
-
Tumor necrosis factor-ɑ
- IL-6:
-
Interleukin-6
- IRS-1:
-
Insulin receptor substrate 1
References
Ma, Y. et al. Identification of biomarkers and immune infiltration characterization of lipid metabolism-associated genes in osteoarthritis based on machine learning algorithms. Aging (Albany NY). 16 (8), 7043–7059 (2024).
Collaborators, G. B. D. O. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the global burden of disease study 2021. Lancet Rheumatol. 5 (9), e508–e22 (2023).
Briggs, A. M. et al. Musculoskeletal Health conditions represent a global threat to healthy aging: a report for the 2015 World Health Organization World Report on Ageing and Health. Gerontologist 56 (Suppl 2), S243–S255 (2016).
Perera, R. S. et al. Age- and sex-specific effects of obesity, metabolic syndrome and its components on back pain: the English Longitudinal Study of Ageing. Jt. Bone Spine. 89 (5), 105366 (2022).
Nie, D. et al. Metabolic syndrome and the incidence of knee osteoarthritis: a meta-analysis of prospective cohort studies. PLoS One. 15 (12), e0243576 (2020).
Sanchez-Santos, M. T. et al. Association of metabolic syndrome with knee and hand osteoarthritis: a community-based study of women. Semin. Arthritis Rheum. 48 (5), 791–798 (2019).
Courties, A., Berenbaum, F. & Sellam, J. The phenotypic approach to osteoarthritis: a look at metabolic syndrome-associated osteoarthritis. Jt. Bone Spine. 86 (6), 725–730 (2019).
Mirjalili, S. R. et al. Which surrogate insulin resistance indices best predict coronary artery disease? A machine learning approach. Cardiovasc. Diabetol. 23 (1), 214 (2024).
Ramdas Nayak, V. K., Satheesh, P., Shenoy, M. T. & Kalra, S. Triglyceride glucose (TyG) index: a surrogate biomarker of insulin resistance. J. Pak. Med. Assoc. 72 (5), 986–988 (2022).
Zhao, Q. et al. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus. Cardiovasc. Diabetol. 20 (1), 190 (2021).
Huang, J. et al. Association between higher triglyceride glucose index and increased risk of osteoarthritis: data from NHANES 2015–2020. BMC Public. Health. 24 (1), 758 (2024).
Wan, H., Cao, H. & Ning, P. Superiority of the triglyceride glucose index over the homeostasis model in predicting metabolic syndrome based on NHANES data analysis. Sci. Rep. 14 (1), 15499 (2024).
Xia, X. et al. Association of triglyceride-glucose index and its related parameters with atherosclerotic cardiovascular disease: evidence from a 15-year follow-up of Kailuan cohort. Cardiovasc. Diabetol. 23 (1), 208 (2024).
Al Akl, N. S., Haoudi, E. N., Bensmail, H. & Arredouani, A. The triglyceride glucose-waist-to-height ratio outperforms obesity and other triglyceride-related parameters in detecting prediabetes in normal-weight Qatari adults: a cross-sectional study. Front. Public. Health. 11, 1086771 (2023).
Dang, K. et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003–2018. Cardiovasc. Diabetol. 23 (1), 8 (2024).
Liu, X., Li, J., He, D., Zhang, D. & Liu, X. Association between different triglyceride glucose index-related indicators and depression in premenopausal and postmenopausal women: NHANES, 2013–2016. J. Affect. Disord. 360, 297–304 (2024).
Chen, Q. et al. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease. Cardiovasc. Diabetol. 23 (1), 232 (2024).
Huang, J. et al. Association between lipid accumulation products and osteoarthritis among adults in the United States: a cross-sectional study, NHANES 2017–2020. Prev. Med. 180, 107861 (2024).
Zhang, X. et al. Association between different triglyceride-glucose index combinations with obesity indicators and arthritis: results from two nationally representative population-based study. Eur. J. Med. Res. 29 (1), 389 (2024).
von Elm, E. et al. The strengthening the reporting of Observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370 (9596), 1453–1457 (2007).
Zhou, Z. et al. Comparative study on the predictive value of TG/HDL-C, TyG and TyG-BMI indices for 5-year mortality in critically ill patients with chronic heart failure: a retrospective study. Cardiovasc. Diabetol. 23 (1), 213 (2024).
Kadier, K. et al. Rheumatoid arthritis increases the risk of heart failure: results from the cross-sectional study in the US population and mendelian randomization analysis in the European population. Front. Immunol. 15, 1377432 (2024).
March, L. M., Schwarz, J. M., Carfrae, B. H. & Bagge, E. Clinical validation of self-reported osteoarthritis. Osteoarthr. Cartil. 6 (2), 87–93 (1998).
Wang, X., Xie, L. & Yang, S. Association between weight-adjusted-waist index and the prevalence of rheumatoid arthritis and osteoarthritis: a population-based study. BMC Musculoskelet. Disord. 24 (1), 595 (2023).
Liu, C., Lai, W., Zhao, M., Zhang, Y. & Hu, Y. Association between the composite dietary antioxidant index and atherosclerotic Cardiovascular Disease in Postmenopausal women: a cross-sectional study of NHANES Data, 2013–2018. Antioxidants (Basel). 12(9) (2023).
Liu, N., Ma, F., Feng, Y. & Ma, X. The association between the dietary inflammatory index and thyroid function in U.S. adult males. Nutrients. 13(10). (2021).
Sun, X. et al. Association between diabetes status and breast cancer in US adults: findings from the US National Health and Nutrition Examination Survey. Front. Endocrinol. (Lausanne). 14, 1059303 (2023).
Johnson, C. L. et al. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat. 2 (161), 1–24 (2013).
Cao, F. et al. Trends and cross-country inequalities in the global burden of osteoarthritis, 1990–2019: a population-based study. Ageing Res. Rev. 99, 102382 (2024).
Zhang, X. et al. Prognostic significance of triglyceride-glucose index in acute coronary syndrome patients without standard modifiable cardiovascular risk factors. Cardiovasc. Diabetol. 23 (1), 270 (2024).
Xuan, W., Liu, D., Zhong, J., Luo, H. & Zhang, X. Impacts of triglyceride glucose-Waist to height ratio on diabetes incidence: a secondary analysis of a Population-based Longitudinal Data. Front. Endocrinol. (Lausanne). 13, 949831 (2022).
Miao, H., Zhou, Z., Yang, S. & Zhang, Y. The association of triglyceride-glucose index and related parameters with hypertension and cardiovascular risk: a cross-sectional study. Hypertens. Res. 47 (4), 877–886 (2024).
Liu, L. et al. Comparison of seven surrogate insulin resistance indexes for prediction of incident coronary heart disease risk: a 10-year prospective cohort study. Front. Endocrinol. (Lausanne). 15, 1290226 (2024).
Qiao, T. et al. Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes: a prospective cohort study. Cardiovasc. Diabetol. 21 (1), 225 (2022).
Zhao, Y. et al. Comparison of six surrogate insulin resistance indexes for predicting the risk of incident stroke: the rural Chinese cohort study. Diabetes Metab. Res. Rev. 38 (7), e3567 (2022).
Liu, Z. et al. Comparison of seven surrogate insulin resistance indexes for predicting the prevalence of carotid atherosclerosis in normal-weight individuals. Front. Public. Health. 11, 1241523 (2023).
Puenpatom, R. A. & Victor, T. W. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad. Med. 121 (6), 9–20 (2009).
Kong, L., Wang, L., Meng, F., Cao, J. & Shen, Y. Association between smoking and risk of knee osteoarthritis: a systematic review and meta-analysis. Osteoarthr. Cartil. 25 (6), 809–816 (2017).
Leung, Y. Y. et al. Cigarette smoking and risk of total knee replacement for severe osteoarthritis among Chinese in Singapore–the Singapore Chinese health study. Osteoarthr. Cartil. 22 (6), 764–770 (2014).
Kwon, H. M. et al. Cigarette smoking and knee osteoarthritis in the elderly: data from the Korean National Health and Nutritional Examination Survey. Exp. Gerontol. 133, 110873 (2020).
Toivanen, A. T. et al. Obesity, physically demanding work and traumatic knee injury are major risk factors for knee osteoarthritis—a population-based study with a follow-up of 22 years. Rheumatol. (Oxford). 49 (2), 308–314 (2010).
Zhu, S. et al. Association of smoking and osteoarthritis in US (NHANES 1999–2018). Sci. Rep. 13 (1), 3911 (2023).
Shen, Z., Wang, Y., Xing, X., Jones, G. & Cai, G. Association of smoking with cartilage loss of knee osteoarthritis: data from two longitudinal cohorts. BMC Musculoskelet. Disord. 24 (1), 812 (2023).
Kang, K. et al. Association between direct and indirect smoking and osteoarthritis prevalence in koreans: a cross-sectional study. BMJ Open. 6 (2), e010062 (2016).
Johnsen, M. B. et al. The association between smoking and knee osteoarthritis in a cohort of Danish patients undergoing knee arthroscopy. BMC Musculoskelet. Disord. 20 (1), 141 (2019).
Levitzky, Y. S. et al. Relation of smoking status to a panel of inflammatory markers: the Framingham offspring. Atherosclerosis 201 (1), 217–224 (2008).
Petrescu, F., Voican, S. C. & Silosi, I. Tumor necrosis factor-alpha serum levels in healthy smokers and nonsmokers. Int. J. Chron. Obstruct Pulmon Dis. 5, 217–222 (2010).
Felson, D. T. & Zhang, Y. Smoking and osteoarthritis: a review of the evidence and its implications. Osteoarthr. Cartil. 23 (3), 331–333 (2015).
Griffin, T. M. & Huffman, K. M. Editorial: insulin resistance: releasing the brakes on synovial inflammation and osteoarthritis? Arthritis Rheumatol. 68 (6), 1330–1333 (2016).
Duclos, M. Osteoarthritis, obesity and type 2 diabetes: the weight of waist circumference. Ann. Phys. Rehabil. Med. 59 (3), 157–160 (2016).
Wang, T. & He, C. Pro-inflammatory cytokines: the link between obesity and osteoarthritis. Cytokine Growth Factor. Rev. 44, 38–50 (2018).
Popa, C., Netea, M. G., van Riel, P. L., van der Meer, J. W. & Stalenhoef, A. F. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J. Lipid Res. 48 (4), 751–762 (2007).
Jin, X. et al. Pathophysiology of obesity and its associated diseases. Acta Pharm. Sin B. 13 (6), 2403–2424 (2023).
Liu, B., Zhang, M., Zhao, J., Zheng, M. & Yang, H. Imbalance of M1/M2 macrophages is linked to severity level of knee osteoarthritis. Exp. Ther. Med. 16 (6), 5009–5014 (2018).
Zhang, H. et al. Synovial macrophage M1 polarisation exacerbates experimental osteoarthritis partially through R-spondin-2. Ann. Rheum. Dis. 77 (10), 1524–1534 (2018).
Zhang, H., Cai, D. & Bai, X. Macrophages regulate the progression of osteoarthritis. Osteoarthr. Cartil. 28 (5), 555–561 (2020).
Acknowledgements
The authors thank NCHS for its research design and data sharing, as well as all the investigators and participants.
Funding
This research was funded by the Basic and Applied Basic Research Foundation of Guangdong Province (No. 2024A1515012910) and the Special Funds for science and technology of Guangdong Province (No. 210715106900976).
Author information
Authors and Affiliations
Contributions
The study idea was designed by Y.M.L., Q.B.Z., D.Y.H. and L.L.; Y.M.L., Q.B.Z. and M.J.L. analyzed and interpreted the data; Y.M.L., Q.B.Z., M.J.L. and J.X.C. were responsible for drafting the manuscript; The manuscript was reviewed by D.Y.H. and L.L. All authors have read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Review Committee of the National Center for Health Statistics (Protocol #98-12, Protocol #2005-06, Continuation of Protocol #2005-06, Protocol #2011-17 and Continuation of Protocol #2011-17). Informed consent was obtained from all the subjects involved in the study.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lan, Y., Zheng, Q., Li, M. et al. Associations between surrogate insulin resistance indexes and osteoarthritis: NHANES 2003–2016. Sci Rep 15, 1578 (2025). https://doi.org/10.1038/s41598-024-84317-z
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-024-84317-z
Keywords
This article is cited by
-
Elevated triglyceride-glucose index and its combination with anthropometric indices as indicators of the risk of new-onset transient ischemic attack: a prospective cohort study
Cardiovascular Diabetology (2025)
-
Association of eight anthropometric indexes related to obesity with the prevalence of clinical osteoarthritis among American adults: a national cross-sectional study
European Journal of Medical Research (2025)
-
Machine learning prediction of osteoarthritis risk from volatile organic compound exposure using SHAP interpretation in US adults
Scientific Reports (2025)






